Ovarian Antibody Screen with Reflex to Titer, IFA
Use
The Ovarian Antibody Screen with Reflex to Titer, IFA, is used to detect the presence of ovarian antibodies in the serum. This assay is typically employed in the evaluation of ovary-related autoimmune conditions. The presence of ovarian antibodies can be indicative of autoimmune oophoritis, which may affect ovarian function and contribute to infertility or premature ovarian failure in women. Reflex testing to titration helps quantify the extent of the antibody presence for further clinical evaluation.
Special Instructions
If the initial screen is positive for ovarian antibodies, the test reflexes to the anti-ovary antibody titer to quantify the presence of antibodies. This additional test will incur an extra charge.
Limitations
False positives may occur, and results should be interpreted in the context of clinical findings and other laboratory tests. Specificity may be affected by cross-reactivity with other autoantibodies. The test is not approved for screening the general population and should be used only in clinically suspected cases.
New York Approved
Methodology
Immunoassay (Immunofluorescence Assay (IFA))
Biomarkers
LOINC Codes
- 21436-1
- 21436-1
Result Turnaround Time
2-17 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
Plastic vial (refrigerated)
Collection Instructions
Draw blood in a plain red-top tube(s), serum gel tube(s) is acceptable. Spin down and send 1 mL of serum refrigerated in a plastic vial.
Causes for Rejection
Gross hemolysis or lipemia
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |